Canada - English - Health Canada

organon canada inc. - asenapine (asenapine maleate) - tablet - 10mg - asenapine (asenapine maleate) 10mg - atypical antipsychotics

Canada - English - Health Canada

mylan pharmaceuticals ulc - clozapine - suspension - 50mg - clozapine 50mg - atypical antipsychotics

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - pentamidine isethionate (unii: v2p3k60da2) (pentamidine - unii:673lc5j4lq) - pentamidine isethionate 300 mg in 3 ml - pentam 300 (pentamidine isethionate for injection) is indicated for the treatment of pneumonia due to pneumocystis carinii . contraindicated in patients with a history of hypersensitivity to pentamidine isethionate.

United States - English - NLM (National Library of Medicine)

seton pharmaceuticals - pentamidine isethionate (unii: v2p3k60da2) (pentamidine - unii:673lc5j4lq) - pentamidine isethionate 300 mg in 300 mg - pentamidine isethionate for injection is indicated for the treatment of pneumonia due to pneumocystis carinii. contraindicated in patients with a history of hypersensitivity to pentamidine isethionate.

United States - English - NLM (National Library of Medicine)

almirall, llc - flurandrenolide (unii: 8eul29xuqt) (flurandrenolide - unii:8eul29xuqt) - flurandrenolide 0.5 mg in 1 g - cordran® (flurandrenolide, usp) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in patients with a history of hypersensitivity to any of the components of these preparations.

United States - English - NLM (National Library of Medicine)

almirall, llc - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole 20 mg in 1 g - xolegel is indicated for the topical treatment of seborrheic dermatitis in immunocompetent adults and children 12 years of age and older. safety and efficacy of xolegel for treatment of fungal infections have not been established. none. risk summary there are no available data on xolegel use in pregnant women to evaluate for a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies with pregnant rats, structural abnormalities (syndactylia and oligodactylia) were observed following oral doses of ketoconazole during organogenesis (see data ). the available data do not allow calculation of relevant comparisons between the systemic exposure of ketoconazole observed in animal studies to the systemic exposure observed in humans after topical use of xolegel. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss or other advers

Canada - English - Health Canada

bausch health, canada inc. - colesevelam hydrochloride - powder for suspension - 3.75g - colesevelam hydrochloride 3.75g - bile acid sequestrants

Canada - English - Health Canada

innomar strategies inc. - clozapine - tablet - 25mg - clozapine 25mg - atypical antipsychotics

Canada - English - Health Canada

innomar strategies inc. - clozapine - tablet - 100mg - clozapine 100mg - atypical antipsychotics

Australia - English - Department of Health (Therapeutic Goods Administration)

stark medical -